The Molecular Biology Society of Japan

[1P-0670] Lobeglitazone, Antidiabetic drug, protects mice from lipogenesis-induced liver injury via inhibiting mTORC1

〇Yu Seol Lee1,2, Jeong Su Park1, Da Hyun Lee1,2, Dong-Kyu Lee3, Sung Won Kwon3,4, Byung-Wan Lee5, Soo Han Bae1 (1.Severance Biomedical Science Institute, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea, 2.Brain Korea 21 PLUS Project for Medical Science, Yonsei University, 3.Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea, 4.College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea, 5.Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea)

Lobeglitazone, Thiazolidinedione, NAFLD, hepatic steatosis

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password